Cytosorbents Corp (CTSO) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Cytosorbents Corp (NASDAQ:CTSO) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 25, 2026. The Healthcare company's…
Read more
